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A B S T R A C T
CD40 is a cell surface receptor which belongs to tumor necrosis factor receptor (TNFR) family members. It
transmits signals that regulate diverse cellular responses such as proliferation, differentiation, adhesion molecule
expression and apoptosis. Unlike other TNFR family members (TRAIL-R, Fas-R and TNFR1), the CD40 cyto-
plasmic tail lacks death domain. However, CD40 is capable of inducing apoptosis in different types of cancer
cells including lymphoma. The apoptotic effect of CD40 is linked to the involvement of Fas, TRAIL or receptor
interacting protein 1 (RIP1) kinase. We have previously shown that CD40 activation has anti-apoptotic or
apoptotic effect in follicular lymphoma (FL) cell lines. In this study, we investigated the mechanism by which
CD40 mediates apoptosis in a follicular lymphoma cell line, HF4.9. We show here that CD40-induced apoptosis
was dependent on caspase-8 activation because caspase-8 specific inhibitor, Z-IETD-FMK completely prevented
apoptosis. Therefore, the involvement of TRAIL, Fas and RIP1 in caspase-8 activation was examined. The exo-
genous TRAIL-induced apoptosis was fully prevented by anti-TRAIL neutralizing antibody. However, the anti-
body had no effect on CD40-induced apoptosis indicating that CD40 did not induce the expression of endogenous
TRAIL in HF4.9 cells. Moreover, the cells were not sensitive to Fas-mediated apoptosis. Interestingly, RIP1
specific inhibitor, necrostatin-1 decreased CD40-induced apoptosis, which showed that RIP1 has a role in cas-
pase-8 activation. In conclusion, the survival or apoptotic effects of CD40-mediated signaling might be related to
the differentiation stages of FL cells.
1. Introduction
CD40 is a transmembrane signaling molecule. It is expressed by a
large variety of cell types such as B cells, dendritic cells, macrophages,
endothelial cells and tumor cells. Whereas, CD40 ligand (CD40L) is
mainly expressed on the activated CD4+ T cells. The widespread ex-
pression of CD40 might indicate that it plays a broader role in human
physiology and diseases pathogenesis (Kawabe et al., 2011; Elgueta
et al., 2009a; Hassan et al., 2014).
CD40-CD40L interaction results in the activation of a variety of
signaling cascades, which ultimately determine the diverse physiologic
effects. For example, CD40 has a critical role in the development of
adaptive immune responses. CD40 signaling rescues germinal center B
cells from B cell receptor-mediated apoptosis and thereby promotes
survival, selection and differentiation of B cells into memory and
plasma cells (Elgueta et al., 2009b; Adem et al., 2015). Moreover, CD40
signaling has been linked to enhanced antigen presentation function
and cytokine release (Companjen et al., 2002; Demangel et al., 2001).
In contrast, a direct growth inhibitory effect of CD40 is observed in
some neoplastic B-cells and different types of cancer cells (Tong and
Stone, 2003; Funakoshi et al., 1994). The different mechanisms of
CD40-induced elimination of cancer cells include induction of en-
dogenous cytotoxic ligands and activation of anti-tumor immune re-
sponses (Eliopoulos et al., 2000; Dilloo et al., 1997). The phenotypic
consequences of CD40 signaling, therefore, appear to be dependent on
the cell types. However, the signaling pathways underlying the differ-
ential responses following CD40 activation are yet to be fully char-
acterized.
Receptor-interacting protein 1 (RIP1) kinase is a multifunctional
protein which contains N-terminal Ser/Thr kinase and a C-terminal
death domain. It has context-specific roles in inflammation, cell sur-
vival and apoptosis (Knox et al., 2011). RIP1 is required for the pro-
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inflammatory and anti-apoptotic functions of tumor necrosis factor α
receptor (TNFR). These RIP1 regulated cellular functions are mediated
by nuclear factor κb (NF-κβ) and mitogen activated protein kinases
(MAPKs) signaling (Festjens et al., 2007). RIP1 is also linked to CD40-
induced apoptosis in carcinoma cells (Knox et al., 2011).
Apoptosis (programmed cell death) can be induced by a variety of
stimuli including TRAIL and Fas. These death ligands activate their
natural death receptors TRAIL-R and Fas-R respectively. The death re-
ceptors (DRs) have an intracellular death domain, which is essential for
transduction of the apoptotic signal. The activation of DRs, therefore,
lead to recruitment of the cytosolic adaptor protein, FADD and caspase-
8, which form the death-inducing signaling complex (DISC). In the
DISC, caspase-8 is activated and promotes apoptosis by activating the
downstream effector caspases, caspase-3/7 (Cullen and Martin, 2009).
Moreover, TNFR can also be involved in apoptosis. The activation of
TNFR by TNFα can lead to the formation of complex IIa, which includes
RIP1, caspase-8 and FADD. The interaction of these proteins within the
complex results in the activation of caspase-8 and induction of apop-
tosis (Yuan and Kroemer, 2010). The cytoplasmic tail of CD40 lacks a
death domain which mediates death signals by Fas and TRAIL re-
ceptors. Thus, the mechanisms of the CD40-inducced apoptosis
pathway are not fully understood. Necrostatin-1 (Nec-1) is a specific
inhibitor of RIP1 kinase and help to examine the requirement of this
kinase in cell death (Ofengeim and Yuan, 2013).
MAPKs control a vast array of physiological and pathological pro-
cesses such as cell growth, inflammation, apoptosis and autoimmunity.
The three well-characterized MAPKs include p38MAPK, ERKs and JNK
(Johnson and Lapadat, 2002). The p38 signaling pathway is linked to
caspase-8 mediated apoptosis in human Burkitt lymphoma B-cells
(Schrantz et al., 2001).
Follicular lymphoma (FL) cells represent neoplastic counterparts of
germinal center B-cells (Kahl and Yang, 2016). Germinal centers (GCs)
are specialized microanatomic structures of lymphoid organs which are
formed when B-cells are activated by their specific antigen and receive
costimulatory signals from helper T-cells. In GC, the activated B-cells
undergo differentiation to centroblast, centrocyte, plasma cells/
memory B-cells (De Silva and Klein, 2015; Oropallo and Cerutti, 2014).
We have previously characterized FL cell lines by their im-
munophenotypic features and response to B-cell receptor stimulation
and cytokines (Eray et al., 2003). Based on their unique features and
responses, HF1A3 and HF4.9 cells can be used as an in vitro model for
centrocyte and centroblast cells respectively. We have also previously
shown that CD40 activation results in differential phenotypic responses
in FL cell lines. In HF1A3 cells, CD40 protects cells from Fas- and
TRAIL-mediated apoptosis (Eeva et al., 2007; Nuutinen et al., 2009).
Whereas, in HF4.9 FL cells, CD40 activation leads to apoptosis
(Nuutinen et al., 2009). In this study, we investigate the mechanism by
which CD40 transduce death signaling molecule in follicular lymphoma
cells, HF4.9. We report here that RIP1 has a role in CD40-mediated
activation of caspase-8, which in turn leads to induction of apoptosis.
2. Materials and Methods
2.1. Cell line and culture conditions
The origin and characteristics of human follicular lymphoma cell
line, HF4.9 has been previously described (Eray et al., 2003). The cells
were cultured in RPMI 1640 medium (Lonza, Belgium) supplemented
with 5% heat inactivated fetal bovine serum (GIBCO, Invitrogen, USA),
2 mM L-glutamine (Lonza), 106 U/ml streptomycin (Lonza), 106 U/ml
penicillin (Lonza), 10 mM HEPS buffer (Lonza), 0.1 mM nonessential
amino acids (Lonza), 1 mM Na-pyruvate (Lonza), 20 μM 2-mercap-
toethanol (Fluka-Chemie, Buch, Switzerland) at 37 °C in a 5% CO2
humidified atmosphere.
2.2. Cell treatments
HF4.9 cells were seeded on 12-well flat bottom polystyrene cell
culture plates (Corning Inc, NY, USA) and treated with 50 μM caspase-8
specific inhibitor, Z-IETD-FMK (Calbiochem, San Diego, USA), 20 μM
RIPK-1 inhibitor, necrostatin-1 (Calbiochem), 10 μM P38MAPK specific
inhibitor, SB203580, (Cell Signaling technology, USA), 50 ng/ml His-
tagged recombinant human soluble killer TRAIL™ (Enzo life sciences,
Farmingdale, NY, USA), 0.25 μg/ml human TRAIL antibody (2E5)
(Enzo life sciences), 10 ng/ml anti-CD95 (Fas) (Upstate Biotechnology,
NY, USA). In order to rule out the immediate effects of serum on
p38MAPK activation, the cells were incubated for 24 h and the treat-
ment group was stimulated by 3.6 μg/ml anti-CD40 antibody for spe-
cific time points. In addition, anti-CD40 antibody was added to cell
culture for the time indicated either alone or following 2 h pre-treat-
ment with inhibitors. The anti-CD40 antibody was provided by Dr.
Matti Kaartinen (Haartman institute, University of Helsinki, Finland).
2.3. Flow cytometric analysis of apoptotic cells
DNA fragmentation was determined by flow cytometric analysis
after propidium iodide (PI) staining. Cells with fragmented DNA were
considered as apoptotic. Fixation and staining of cells were performed
according to a standard protocol. In brief, at the end of stimulation
times samples containing one million cells were collected, resuspended
in ice-cold PBS and fixed with ice-cold 70% v/v ethanol. After overnight
incubation at+4 °C, cells were centrifuged at 1500 RPM for 10 min,
resuspended in PBS containing 150 μg/ml RNAase (Sigma, St. Louis
USA) and incubated for 1 h at+50 °C. PI (Molecular Probes, Sigma)
was added to the final concentration of 8 μg/ml and incubation was
further continued for 2 h at+37 °C. FACSCanto II flow cytometer with
FACSDiva version 6.1.2 software (Becton Dickinson, USA) was used for
the analysis.
2.4. Preparation of whole cell lysates
At the end of stimulation times, two million cells were collected,
washed in PBS and centrifuged at 1500 RPM for 5 min. The cell pellet
was resuspended with lysis buffer containing 20 mM Tris–HCl (pH8.0),
2 mM EDTA, 3%NP-40, 100 mM NaCl, 50 mM NaF, 1 mM PMSF, 1 mM
VO4, 5 μg/ml aprotinin, and 5 μg/ml leupeptin. After 1 h of incubation
on ice, samples were centrifuged at 13,000 RPM for 15 min,+4 °C. The
protein concentration of the cell lysates was measured, equalized with
SDS-PAGE buffer (0.125 M Tris-Cl pH 6.8, 4% SDS, 20% glycerol, 10%
2-mercaptoethanol, bromophenolblue) and boiled for 5 min.
2.5. Western blot analysis
Equal amount of protein from each sample was loaded and sepa-
rated through 12% or 15% SDS-PAGE gel. Separated proteins were
transferred to nitrocellulose membranes (GE Healthcare Life sciences,
UK). Membranes were blocked with 1x TBS containing 3% BSA and
0.1% Tween-20 at room temperature. Then the membranes were in-
cubated overnight at + 4 °C with the primary antibodies (anti-caspase-
8, anti-caspase-3, phospho-P38MAPK, total p38MAPK and MAPKAPK-
2). The membranes were washed three times with 1x TBS and incubated
with horseradish peroxidase (HRP)-conjugated goat anti-rabbit anti-
body (Zymed laboratories Inc, California, USA). Diluted in 3% BSA for
40 minutes at room temperature. The membranes were washed three
times with 1x TBS. Finally, the membranes were developed for the
appropriate time period that yields the desired results using enhanced
chemiluminescence detection system (GE Healthcare Life sciences).
2.6. Statistical analysis
Statistical analysis was performed using GraphPad Prism 5. The
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statistical difference between groups was determined with student’s t-
test. P value<0.05 were considered statistically significant.
3. Results
3.1. CD40 stimulation triggers apoptosis through caspase-8 activation
CD40 stimulation in some lymphomas such as Burkitt lymphoma
results in apoptosis through up-regulation of Bax, a pro-apoptotic Bcl-2
family protein (Szocinski et al., 2002). CD40 can also induce caspase-8
mediated apoptosis indirectly through death receptors (Eliopoulos
et al., 2000). We have previously shown that CD40 activation in HF4.9
cells leads to apoptosis (Nuutinen et al., 2009), however, the me-
chanism was not investigated. Therefore, in this study we examined the
possible pathways which could be involved in CD40-mediated apop-
tosis in HF4.9 cells. Cells were cultured in medium containing anti-
CD40 antibody and collected at 4, 8, 12, 16 and 24 h. DNA fragmen-
tation was measured by PI staining and cells with fragmented DNA
were considered as apoptotic. The number of apoptotic cells started to
increase after 4 h and continued to increase until 24 h (Fig. 1A). Next,
we investigated whether apoptosis was mediated through activation of
caspase-8 and caspase-3. Cells were incubated for 24 h with anti-CD40
antibody. At the end of stimulation time the cells were collected, pro-
teins were isolated and immunoblotting was performed. Actin antibody
was used to control that there was an equal amount of protein in each
sample. Activated/cleaved caspase-8 and caspase-3 were detected
(Fig. 1B). To determine whether caspase-8 was the only initiator of
caspase-3 activation, cells were treated with 50 μM Z-IETD-FMK (cas-
pase-8 specific inhibitor) for 2 h prior to addition of anti-CD40 antibody
for 16 h and collected for DNA fragmentation and immunoblotting
analysis. Z-IETD-FMK completely blocked caspase-3 activation and
apoptosis (Fig. 2A, B).
3.2. CD40-mediated apoptosis does not involve induction of death ligands
CD40 induces apoptosis in carcinoma cells through activation of
cytotoxic ligands of the tumor necrosis factor superfamily (Eliopoulos
et al., 2000). To examine this possibility in follicular lymphoma cells,
we investigated the role of TRAIL and Fas in CD40-mediated apoptosis.
TRAIL induced apoptosis in HF4.9 cells. However, cells were not sen-
sitive to Fas (Fig. 3C). To determine the role of endogenous TRAIL in
CD40-mediated apoptosis, we used anti-TRAIL antibody (2E5). Cells
were incubated with TRAIL, anti-CD40 antibody, and/or 2E5 antibody
for 16 h. The 2E5 antibody was added 2 h prior to addition of TRAIL or
anti-CD40 antibody. After incubations cells were collected and DNA
fragmentation was measured by PI-staining. The 2E5 antibody com-
pletely prevented TRAIL-induced apoptosis. Whereas, the antibody had
no effect on CD40-induced apoptosis confirming that endogenous
TRAIL was not induced.
3.3. CD40-induced apoptosis requires RIP1
To identify the pathway leading to caspase-8 activation upon CD40
stimulation, we examined the role of RIP1 kinase which has been linked
to CD40-mediated apoptosis (Knox et al., 2011). Cells were incubated
with RIP1 specific inhibitor (Nec-1) and/or anti-CD40 antibody for
16 h. After incubation cells were collected for PI-staining and im-
munoblotting. Nec-1 partially inhibited apoptosis, as the proportion of
apoptotic cells decreased from 40% to 25%, (p < 0.001). The decrease
in apoptosis also correlated with the level of active caspase-3 (Fig. 3A,
B)
Fig. 1. Kinetics of CD40-induced apoptosis in HF4.9 cells. A) Cells were treated with anti-
CD40 antibody for 4, 8, 12, 16 and 24 h. After incubation the cells were collected, fixed
and stained with PI and analyzed by flow cytometry. Cells with fragmented DNA are
considered as apoptotic. The data are presented as mean ± SEM from three independent
experiments. B) Cells were treated with anti-CD40 antibody for 24 h. After stimulation the
cells were collected and total cell lysates were prepared. The activation of caspase-8 and
caspase-3 were detected by immunoblotting. Actin was used to ensure that there was
equal amount of protein in each sample.
Fig. 2. CD40 mediates apoptosis by caspase-8 activation. A) Cells were treated with
caspase-8 specific inhibitor, Z-IETD-FMK for 2 h prior to addition of anti-CD40 antibody
for 16 h. After incubation the cells were collected for PI and western blot analysis. DNA
fragmentation of cells was analyzed by flow cytometry after PI staining. The data are
presented as mean ± SEM from three independent experiments. B) The activation of
caspase-3 was detected by western blot. Actin was used to ensure that there was equal
amount of protein in each sample.
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3.4. CD40-induced caspase-8 activation is not dependent on p38 MAPK
P38 MAPK activation by TGFβ involves FADD-independent activa-
tion of caspase-8 (Schrantz et al., 2001). We therefore examined the
activity of p38 MAPK and its effect on apoptosis. Cells were incubated
with anti-CD40 antibody for 1, 4, 8, 16 and 24 h. After incubations cells
were collected, proteins were isolated and immunoblotting was per-
formed using phospho-p38 MAPK and total p38MAPK antibodies. In-
terstingly, CD40 stimulation led to phosphorylation of p38MAPK,
which was detected from the earliest time points until end of
stimulation (Fig. 4A). Therefore, we investigated the role of phospho-
p38MAPK in CD40-mediated apoptosis by using p38MAPK specific in-
hibitor, SB203580. Cells were treated with 10 μM SB203580 for 2 h
prior to addition of anti-CD40 antibody for 16 h. Cells were collected
for DNA fragmentation and immunoblotting analysis. Interstingly,
CD40-induced phosphorylation of MAPKAPK-2 (the downstream target
of p38MAPK) was detected as a phosphorylation specific MAPKAPK-2
band shift on SDS-PAGE. Moreover, the phosphorylation was inhibited
by SB203580 but SB203580 did not prevent CD40-induced apoptosis
(Fig. 4B, C).
4. Discussion
CD40 is expressed by hematopoietic and non-hematopoietic cells
(Elgueta et al., 2009a). Although, it has important pro-survival func-
tions in the development of humoral immunity, CD40L-CD40 interac-
tion in some cell types leads to the induction of apoptosis. In the present
study, we examined the apoptotic pathway involved in CD40-mediated
apoptosis in human follicular lymphoma (FL) cells. As CD40-induced
apoptosis in HF4.9 cells is fully prevented by the inhibition of caspase-8
activation, we focused on cellular death inducing proteins which have a
key role in caspase-8 regulation. In this regard, the role of RIP1, TRAIL,
Fas and p38MAPK was examined. We report here that TRAIL, Fas and
p38MAPK have no role in CD40-induced apoptosis, whereas RIP1 was
involved in apoptosis because RIP1 inhibition by Nec-1 partially pre-
vented the apoptosis. The inability of Nec-1 to completely abolish
Fig. 3. RIP1 has a role in CD40-mediated apoptosis in HF4.9 cells. A) Cells were treated
with RIP1 specific inhibitor, Necrostatin-1 for 2 h prior to addition of anti-CD40 antibody
for 16 h. After incubation the cells were collected for PI and western blot analysis. Cells
with fragmented DNA were analyzed by flow cytometry. The data are presented as
mean ± SEM from three independent experiments. The statistical significance of dif-
ference was determined using student’s t-test; **p < 0.001. B) The activation of caspase-
3 was detected by western blot. To control the equal amount of protein was loaded on the
gel, antibody against actin was used. C) Cells were treated with TRAIL, anti-CD40 anti-
body and Fas. Cells were also treated with anti-TRAIL antibody for 2 h prior to addition of
TRAIL. After incubation time the cells were collected for PI analysis. The data are pre-
sented as mean ± SEM from three independent experiments.
Fig. 4. p38MAPK has no involvement in CD40-induced caspase-8 activation. A) Cells
were treated with anti-CD40 antibody for 1, 4, 8, 16, and 24 h. After incubation time the
cells were collected for western blot analysis. The level of phospho-p38MAPK and total
p38MAPK were detected by western blot. B) Cells were treated with p38MAPK specific
inhibitor, SB203580 for 2 h prior to addition of anti-CD40 antibody for 16 h. After in-
cubation the cells were collected for PI and western blot analysis. The data are presented
as mean ± SEM from three independent experiments. The statistical significance of
difference was determined using student t-test. C) The levels of phospho-p38MAPK,
MAPKAPK-2 and actin were detected by western blot.
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CD40-mediated apoptosis indicates that caspase-8 is activated by ad-
ditional death signals. Consistent with our findings, the importance of
RIP1 in CD40-mediated apoptosis in carcinoma cells has been demon-
strated (Knox et al., 2011). Moreover, CD40 ligation is found to induce
endogenous cytotoxic ligands (Fas and/or TRAIL) in carcinoma cells
and hepatocyte (Eliopoulos et al., 2000; Afford et al., 1999). Therefore,
the ability of CD40 to induce these death ligands seems to be cell type
specific. Altogether, these data demonstrate that there are multiple
proteins/kinases which regulate CD40-mediated caspase-8 activation.
It is well known that RIP1 is crucially important in development and
maintenance of B-cells (Zhang et al., 2011). However, RIP1 has also
contradicting cellular functions such as cell survival or apoptosis. Our
data strengthen the fact that the different cellular responses following
CD40 stimulation in GC-derived B-cells could be determined by ma-
turational stages of the cells. GCs are microanatomic structures where
B-cells proliferate, mutate their receptor genes, differentiate, and
switch isotype of their antibodies. The GC structure is comprised of a
dark zone (DZ) and a light zone (LZ). DZ contains highly proliferating
B-cells (Centroblasts). These cells undergo somatic hypermutation
(SHM). SHM increases BCR diversity and thereby increases chances of
producing B-cells with high affinity to antigens. However, SHM has also
a downside, because it leads to the production of B-cells which are
capable of recognizing self-antigens. In the LZ, therefore, B-cells (cen-
trocytes) are subjected to selection. T helper cells-derived co- stimula-
tory signals such as CD40 are delivered to non-self-reactive B-cells to
rescue them from elimination (De Silva and Klein, 2015; Oropallo and
Cerutti, 2014). We have previously shown that CD40 rescues HF1A3
cells from B-cell receptor mediated apoptosis (Adem et al., 2015; Eeva
et al., 2003). Based on our findings, the different outcome of CD40
signaling in HF1A3 (representing centrocyte) and HF4.9 (representing
centroblast) (Eray et al., 2003) cells seems to depend on their devel-
opmental stage. Therefore, we speculate that CD40-mediated signaling
might induce apoptosis in cells which undergo SHM, thereby pre-
venting the production of self-reactive B-cells.
In summary we have shown that anti-CD40 antibody induces RIP1
dependent apoptosis in human follicular lymphoma cells, HF.49. The
pro-apoptotic function of RIP1 is independent of the involvement of
cytotoxic ligands. These findings may also provide insights into the role
of RIP1 in differential stages of germinal center B-cells. In addition to
RIP1, CD40-induced signaling pathways which regulate caspase-8 ac-
tivation will be an interesting area for future studies (Fig. 5).
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